Literature DB >> 7713506

The location of a disease-associated polymorphism and genomic structure of the human 52-kDa Ro/SSA locus (SSA1).

H Tsugu1, R Horowitz, N Gibson, M B Frank.   

Abstract

Sera from approximately 30% of patients with systemic lupus erythematosus (SLE) contain high titers of autoantibodies that bind to the 52-kDa Ro/SSA protein. We previously detected polymorphisms in the 52-kDa Ro/SSA gene (SSA1) with restriction enzymes, one of which is strongly associated with the presence of SLE (P < 0.0005) in African Americans. A higher disease frequency and more severe forms of the disease are commonly noted among these female patients. To determine the location and nature of this polymorphism, we obtained two clones that span 8.5 kb of the 52-kDa Ro/SSA locus including its upstream regulatory region. Six exons were identified, and their nucleotide sequences plus adjacent noncoding regions were determined. No differences were found between these exons and the coding region of one of the reported cDNAs. The disease-associated polymorphic site suggested by a restriction enzyme map and confirmed by DNA amplification and nucleotide sequencing was present upstream of exon 1. This polymorphism may be a genetic marker for a disease-related variation in the coding region for the protein or in the upstream regulatory region of this gene. Although this RFLP is present in Japanese, it is not associated with lupus in this race.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7713506     DOI: 10.1006/geno.1994.1664

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  10 in total

1.  Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus.

Authors:  B P Tsao; R M Cantor; K C Kalunian; C J Chen; H Badsha; R Singh; D J Wallace; R C Kitridou; S L Chen; N Shen; Y W Song; D A Isenberg; C L Yu; B H Hahn; J I Rotter
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

2.  New coupled-particle light-scattering assay for detection of Ro/SSA (52 and 60 kilodaltons) and La/SSB autoantibodies in connective tissue diseases.

Authors:  N Bizzaro; F Bonelli; E Tonutti; R Tozzoli; D Villalta
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

3.  Structural organization and mammary-specific expression of the butyrophilin gene.

Authors:  S L Ogg; M V Komaragiri; I H Mather
Journal:  Mamm Genome       Date:  1996-12       Impact factor: 2.957

4.  The 52 000 MW Ro/SS-A autoantigen in Sjögren's syndrome/systemic lupus erythematosus (Ro52) is an interferon-gamma inducible tripartite motif protein associated with membrane proximal structures.

Authors:  Davd A Rhodes; Gudrun Ihrke; Anna T Reinicke; Georg Malcherek; Michael Towey; David A Isenberg; John Trowsdale
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

Review 5.  Genetics of transfusion recipient alloimmunization: can clues from susceptibility to autoimmunity pave the way?

Authors:  Zohreh Tatari-Calderone; Naomi L C Luban; Stanislav Vukmanovic
Journal:  Transfus Med Hemother       Date:  2014-11-17       Impact factor: 3.747

6.  Autoantigen TRIM21/Ro52 as a Possible Target for Treatment of Systemic Lupus Erythematosus.

Authors:  Ryusuke Yoshimi; Yoshiaki Ishigatsubo; Keiko Ozato
Journal:  Int J Rheumatol       Date:  2012-06-04

Review 7.  Clinical and pathological roles of Ro/SSA autoantibody system.

Authors:  Ryusuke Yoshimi; Atsuhisa Ueda; Keiko Ozato; Yoshiaki Ishigatsubo
Journal:  Clin Dev Immunol       Date:  2012-12-06

8.  52-kD SS-A/Ro: genomic structure and identification of an alternatively spliced transcript encoding a novel leucine zipper-minus autoantigen expressed in fetal and adult heart.

Authors:  E K Chan; F Di Donato; J C Hamel; C E Tseng; J P Buyon
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307

9.  Genomics in premature infants: a non-invasive strategy to obtain high-quality DNA.

Authors:  Mariam Said; Clint Cappiello; Joseph M Devaney; Daniele Podini; Alana L Beres; Stanislav Vukmanovic; Khodayar Rais-Bahrami; Naomi C Luban; Anthony D Sandler; Zohreh Tatari-Calderone
Journal:  Sci Rep       Date:  2014-03-06       Impact factor: 4.379

10.  TRIM21 Polymorphisms are associated with Susceptibility and Clinical Status of Oral Squamous Cell Carcinoma patients.

Authors:  Chun-Yi Chuang; Yi-Chung Chien; Chiao-Wen Lin; Chia-Hsuan Chou; Shuo-Chueh Chen; Chun-Lin Liu; Li-Yuan Bai; Shun-Fa Yang; Yung-Luen Yu
Journal:  Int J Med Sci       Date:  2021-06-11       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.